An antiviral drug Truvada may soon become the next solution to HIV prevention, while scientists continue to dig for a vaccine.
| by RT | 2012 |
The FDA is likely to approve the medicine for ‘pre-exposure prophylaxis’ by June 15.
The FDA is likely to approve the medicine for ‘pre-exposure prophylaxis’ by June 15.